Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Tom Fleisher"'
Autor:
Minhua Su, Tom Fleisher, Inna Grosheva, Melanie Bokstad Horev, Malgorzata Olszewska, Camilla Ciolli Mattioli, Haim Barr, Alexander Plotnikov, Silvia Carvalho, Yoni Moskovich, Mark D. Minden, Noa Chapal-Ilani, Alexander Wainstein, Eirini P. Papapetrou, Nili Dezorella, Tao Cheng, Nathali Kaushansky, Benjamin Geiger, Liran I. Shlush
Publikováno v:
iScience, Vol 27, Iss 4, Pp 109443- (2024)
Summary: Spliceosome machinery mutations are common early mutations in myeloid malignancies; however, effective targeted therapies against them are still lacking. In the current study, we used an in vitro high-throughput drug screen among four differ
Externí odkaz:
https://doaj.org/article/0f0b14d6b7ce4b4cbbdae7d1354a29e0
Autor:
Xiying Fan, Ronald L. Hornung, Theo Heller, Stefania Pittaluga, Monica Santin-Duran, Duane W. Wong, Calman Prussin, Ashish Jain, David E. Kleiner, Ronald Fayer, Pamela Edmonds, Joao Bosco Oliveira, Bhaskar Upadhyaya, Aaron Bodansky, Chi Ma, Ester Williams, Christopher Koh, Liming Wu, Gulbu Uzel, Tom Fleisher
Publikováno v:
Clinical immunology (Orlando, Fla.). 143(2)
X-linked hyper-IgM syndrome (XHM) is a combined immune deficiency disorder caused by mutations in CD40 ligand. We tested CP-870,893, a human CD40 agonist monoclonal antibody, in the treatment of two XHM patients with biliary Cryptosporidiosis. CP-870